| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4024156 | Journal Français d'Ophtalmologie | 2011 | 6 Pages |
Abstract
Best's disease is an autosomal-dominant macular dystrophy, which might lead to choroidal neovascularization. The case of a 9-year-old boy followed up for a Best's disease is hereby reported. The boy was referred to our service department for a decrease in visual acuity in his right eye. Ophthalmoscopic examination revealed a foveolar vitelliform lesion, complicated by a choroidal neovascularization. The patient received a single intravitreal bevacizumab injection, which led to a complete resolution of intraretinal fluid and a significant reduction in neovascularization size. Visual acuity also improved. This case underlines the efficiency efficacy of intravitreal anti-VEGF therapy for choroidal neovascularization in Best's disease.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
J. Perol, B. Wolff, J.-A. Sahel, Y. Le Mer,